UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
UC San Diego studies using human cell lines and tumors grown in mice provide early evidence that inhibiting RNA-binding proteins, a previously overlooked family of molecules, might provide a new approach for treating some cancers.
Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.
As the opioid tramadol has grown in popularity so too have documented cases of adverse effects. In a new study, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego show that patients who take tramadol are at greater risk for hypoglycemia, abnormally low blood sugar.
UC San Diego researchers report that climate change is a chronic mental health stressor, and promotes a variety of mental health problems. The 2018 Camp Fire is a case study.
Subtle differences in cognition may help identify individuals at risk for becoming dependent years later upon others to complete daily activities, such as managing medications or finances and other essential activities.
Steven M. Strauss and Lise N. Wilson have gifted $3.25 million to UC San Diego Health Sciences to open a new research center geared toward creating novel treatment options that will slow or halt the progression of heart disease.
San Diego Magazine, October 29
Imperial Valley Weekly, November 2
FOX 5, November 5
Escondido Times-Advocate, November 5
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
